Search clinical trials for: Orvepitant

Total 11 results

Nerre Therapeutics Ltd.

Withdrawn

A Study of the Efficacy and Safety of Orvepitant in Subjects With Pruritus Associated With Atopic Dermatitis (SOOTHE)

Pruritus | Atopic Dermatitis
GlaxoSmithKline

Completed

Food and Relative Bioavailability Study (Food/rel BA)

Depressive Disorder

Italy
Nerre Therapeutics Ltd.

Completed

Mass Balance Study of [14C]-Orvepitant Oral Solution in Healthy Male Subjects

Healthy

United Kingdom
GlaxoSmithKline

Completed

Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder

Post-Traumatic Stress Disorder

United States
GlaxoSmithKline

Terminated

A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder (Orvepitant MDD)

Depressive Disorder

United States, Canada
GlaxoSmithKline

Terminated

A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder (orvepitant MDD)

Depressive Disorder, Major

United States, Canada
Nerre Therapeutics Ltd.

Completed

A Dose-ranging Study of Orvepitant in Patients With Chronic Refractory Cough

Chronic Refractory Cough

United States, Canada, United Kingdom
Nerre Therapeutics Ltd.
Pharm-Olam International

Active, not recruiting

Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis (IPF-COMFORT)

Cough | Idiopathic Pulmonary Fibrosis

United States, United Kingdom, Netherlands
ArQule, Inc. (a wholly owned subsidiary of Merck...

Completed

An Extension Study for Patients Previously Treated With ARQ 501

Cancer

United States
Nerre Therapeutics Ltd.

Completed

A Pharmacokinetic Study of the Effect of Itraconazole Exposure to Orvepitant in Healthy Volunteers

Pharmacokinetic Study in Healthy Male Volunteers

United Kingdom
GlaxoSmithKline

Completed

28-day Repeat Dose and Drug Interaction Study With Orvepitant (GW823296)

Depressive Disorder

Germany

3

Subscribe